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Hemorrhage is the major cause of cardiac arrest developing in the operating room. Many human factors including 
surgical procedures, transfusion practices, blood supply, and anesthetic management are involved in the process 
that leads to hemorrhage developing into a critical situation. It is desirable for hospital transfusion committees to 
prepare hospital regulations on ‘actions to be taken to manage critical hemorrhage’ , and practice the implementation 
of these regulations by simulated drills. If intraoperative hemorrhage seems to be critical, a state of emergency 
should immediately be declared to the operating room staff, the blood transfusion service staff, and blood bank staff 
in order to organize a systematic approach to the ongoing problem and keep all responsible staff working outside the 
operating room informed of events developing in the operating room. To rapidly deal with critical hemorrhage, not 
only cooperation between anesthesiologists and surgeons but also linkage of operating rooms with blood transfusion 
services and a blood bank are important. When time is short, cross-matching tests are omitted, and ABO-identical 
red blood cells are used. When supplies of ABO-identical red blood cells are not available, ABO-compatible, non-
identical red blood cells are used. Because a systematic, not individual, approach is required to prevent and manage 
critical hemorrhage, whether a hospital can establish a procedure to deal with it or not depends on the overall 
capability of critical and crisis management of the hospital. (Korean J Anesthesiol 2011; 60: 151-160)
Key Words:  Crisis management, Hemorrhage, Risk management, Transfusion.
Risk and crisis management in intraoperative hemorrhage: 
Human factors in hemorrhagic critical events
Kazuo Irita
Department of Anesthesiology and Critical Care Medicine, Kyushu University Hospital, Fukuoka, Japan
Received: September 7, 2010.  Revised: September 27, 2010.  Accepted: September 27, 2010.
Corresponding author: Kazuo Irita, M.D., Ph.D., Department of Anesthesiology and Critical Care Medicine, Kyushu University Hospital, 3-1-1, 
Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Tel: 81-92-642-5959, Fax: 81-92-642-5174, E-mail: irita@kuaccm.med.kyushu-u.ac.jp
    This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
CC
    Hemorrhage is the No. 1 killer in the operating room all 
over the world. The Japanese Society of Anesthesiologists 
(JSA) started an annual survey of anesthesia-related critical 
events in the operating room in 1992. JSA sends confidential 
questionnaires to JSA-certified training hospitals, and then 
collects and analyzes the responses. Cardiac arrest as well 
as severe hypotension, severe hypoxemia, and other events 
that might develop into cardiac arrest or permanent disability 
of the central nervous system are registered. In this survey 
between 2004 and 2008 (n = 5,235,940), cardiac arrest was 
found to develop in 4.38/10,000 anesthetics and death within 
30 postoperative days following intraoperative critical events 
was found to occur in 6.85/10,000 anesthetics [1]. Hemorrhage 
was responsible for 33% of cardiac arrests and 47% of deaths. 152 www.ekja.org
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Although two-thirds of the cases of hemorrhagic death occurred 
in emergency operations that were undertaken to save the 
lives of bleeding patients, one-third of them were caused by 
surgical procedures. Supplemental surveys concerning critical 
hemorrhage in the operating room that were also conducted by 
JSA between 2003 and 2005 revealed that hemorrhagic events 
were complicated by many human factors and then developed 
into critical hemorrhage [2]. Taking the results of another 
survey by JSA into consideration, blood loss exceeding 5,000 ml 
developed in 15 patients a day in the operating rooms of JSA-
certified training hospitals, critical hemorrhage developed in 2.6 
patients a day, and hemorrhagic death occurred in one patient 
a day.
    In this review, I will discuss how we can prevent critical 
hemorrhage and how we can deal with those cases caused 
by surgical procedures in particular. Each surgeon and each 
anesthesiologist were partly responsible for critical hemorrhage. 
However, what we need is a systematic approach. We have to 
eradicate sources of error as much as possible.
Critical Hemorrhage
Rapid loss of large amounts of blood 
    Massive hemorrhage can be defined as follows: (i) blood loss 
exceeding circulating blood volume within a 24-hour period, 
(ii) blood loss of 50% of circulating blood volume within a 
3-hour period, (iii) blood loss exceeding 150 ml/min, or (iv) 
blood loss that necessitates plasma and platelet transfusion 
[3], although there is no universal definition. However, we 
should note that critical hemorrhage can occur even though 
the hemorrhage does not meet the above criteria. Surveys 
concerning critical hemorrhage caused by surgical procedures 
(n = 1,105), which were conducted by JSA between 2003 to 
2005, revealed that 63% of patients had blood loss of more than 
one circulating blood volume, and that 37% of them had blood 
loss of more than two circulating blood volumes. They also 
revealed that 51% of patients had blood loss exceeding 120 ml/
min, and that 31% of them had blood loss exceeding 240 ml/
min, although maximum hemorrhagic speed was not reported 
in 22% of patients [2]. The results clearly showed that we have 
to consider the volume and the speed of blood transfusion to 
save a patient’s life. The results also suggested that blood loss 
of under one circulating blood volume or 120 ml/min was 
responsible for critical hemorrhage, indicating that blood loss 
that does not meet a general definition of massive hemorrhage 
can threaten patients in the operating room: some factors other 
than the volume or the speed of blood loss threatened surgical 
patients. Patient’s ischemic co-morbidity, preceding anemia, 
delay of blood transfusion, and delay of blood supply may make 
hemorrhage critical regardless of blood loss. 
Human factors affecting hemorrhagic critical events
    Anesthesiologists evaluated factors affecting hemorrhagic 
critical events caused by surgical procedures as shown in Fig. 1 
[2]. Adhesion or invasion of diseased tissues is usually judged 
to be unavoidable. However, failure to foresee adhesion or 
invasion might be responsible for hemorrhage. While foreseeing 
these factors is impossible, unreasonable lysis of adhesion or 
resection in circumstances where red blood cells (RBCs) are not 
readily available might be responsible for critical hemorrhage.
    Surgical problems include inappropriate judgments (27%), 
poorly developed skills (26%), delay of recognizing bleeding 
during endoscopic procedures (3%), and incorrect handling 
of surgical devices (3%). When critical events develop in the 
operating room, communication among the staffs concerned 
is important to avoid exacerbation of critical conditions caused 
by hemorrhage and to minimize the adverse effects of massive 
hemorrhage on patients. However, communication between 
surgeons and anesthesiologists seemed to be poor in 34% of the 
cases.
    Details of anesthetic management factors responsible for 
critical events are listed in Table 1. These include hypovolemia 
just prior to bleeding (12%), shortage of supportive anesthesio-
logists (10%), delay in ordering additional blood products 
(9%), shortage of rapid infusion/transfusion apparatus (8%), 
delayed judgment to start blood transfusion (7%), and delayed 
addition of venous routes (5%). Hypovolemia prior to bleeding 
might be caused by restricted fluid management [4] and the 
difficulty of evaluating intravascular volume. Delayed judgment 
to start blood transfusion might be caused by a basic policy 
to avoid allogeneic blood transfusion because of its infectious 
Fig. 1. Factors affecting hemorrhagic critical events caused by 
surgical procedures. Analysis of 1,105 patients who are registered in 
the surveys conducted by JSA between 2003 and 2005 [2].153 www.ekja.org
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and immunosuppressive effects [5], underestimation of blood 
loss due to bleeding into intra-abdominal/intra-thoracic/
intra-vaginal cavities, or the absence of monitoring devices to 
measure hemoglobin levels continuously. It is unclear whether 
allogeneic blood transfusion during the perioperative period 
might affect long-term survival after surgery [6,7]. Difficulty to 
predict future blood loss and administrative pressure to avoid 
ordering too many blood products will cause delay in ordering 
additional blood products. Delay in ordering additional blood 
products, shortage of supportive anesthesiologists, and shortage 
of rapid infusion/transfusion apparatus cause delay in blood 
transfusion resulting in life-threatening hypovolemia and/or 
anemia. Because the maximal speed of blood loss exceeded 
120 ml/min in about half of the cases of critical hemorrhage, 
maintaining multiple large-bore blood access is a prerequisite 
for saving a patient’s life.
    We anesthesiologists should be cautious when controlling 
anesthesia depth. Hypotension induced by anesthetic drugs 
affected critical events in 1.9% of patients developing life-
threatening hemorrhage. More importantly, hypertension, 
bucking, and patient movement, which are manifestations of 
light anesthesia or shortage of muscle relaxants, were reported 
to induce massive hemorrhage. Therefore, maintaining 
adequate levels of anesthesia depth is important to avoid 
anesthesia-related or anesthesia-induced critical hemorrhage.
    Problems of blood supply included delayed delivery of blood 
products from blood banks to hospitals (9%), exhaustion of 
time by cross-matching (8%), shortage of manpower during 
nights or weekends (6%), delayed delivery of blood products 
from blood transfusion services to the operating room (4%), 
and exhaustion of time by irradiation in blood transfusion 
services (4%). In Japan, the safe limit of time required for 
emergency delivery of blood products from blood banks to 
hospitals seemed to be between 30 and 45 min (unpublished 
data). Blood-type examination takes 9+/-7 min by manual 
procedures and 12+/-7 min by automatic procedures. Cross-
matching takes 25+/-12 min by manual procedures and 
29+/-10 min by automatic procedures [8]. The time required 
for blood-type examination and cross-matching might be 
longer during nights or weekends. We should also consider the 
following points: (i) withdrawing blood samples from a patient 
and then transporting them to blood transfusion services will 
take about 15 min, (ii) transfusing multiple trauma patients 
with ABO-identical RBCs instead of emergency O-type RBCs 
is associated with a higher risk of incompatible transfusion 
(wrong blood in tube) [9], and (iii) blood testing during nights 
or weekends by untrained staff can cause errors in blood-type 
judgment and in clerical work. Therefore, we should transfuse 
uncross-matched O-type RBCs in extreme emergencies until 
the blood-type is known, and then transfuse uncross-matched 
type-specific RBCs. The only situation in which we can transfuse 
fully cross-matched RBCs is when time permits. Manpower 
affects the outcome of hemorrhage or massive hemorrhage. It 
has been demonstrated that the mortality rate due to obstetric 
hemorrhage was significantly higher in hospitals with only 1 
obstetrician than in those with 2 or more obstetricians [10]. The 
effects of manpower shortage easily become overt during nights 
or weekends, especially when a patient is in a severe condition. 
Overall survival from intraoperative massive hemorrhage 
during emergency surgery was not affected by time of day or 
day of week. However, when blood loss exceeded 200 ml/kg, the 
survival rate was significantly lower during nights or weekends 
than during day/evening (unpublished data). In Japan, half 
of hospitals with more than 500 beds purchase un-irradiated 
blood products. Because in-hospital irradiation takes between 5 
and 15 min, it delays the delivery of blood products from blood 
transfusion services.
    These human factors including adhesion or invasion were 
reported to be involved in 191% of 1,105 cases of critical 
hemorrhage caused by surgical procedures, indicating that 
multiple human factors are involved in critical hemorrhage 
[2]. This implies that drastic changes in patient care including 
changes in surgical procedures, anesthetic management, 
blood transfusion practices, and practices in blood transfusion 
services are required to save patients’ lives.
    We anesthesiologists should also be cautious of complications 
caused by massive and/or rapid transfusion. Hypothermia and 
hyperkalemia, both of which might cause cardiac arrest, have 
been reported to complicate 2.9% and 1.2% of patients with 
massive hemorrhage, respectively. Hypothermia might induce 
Table 1. Anesthetic Management that Complicated Surgical 
Hemorrhage. Analysis of 1,105 Patients Who Developed Critical 
Hemorrhage due to Surgical Procedures
Factors affecting critical hemorrhage
Patient 
concerned (%)
Infusion practices
    Hypovolemia prior to massive hemorrhage
Transfusion practices
    Delayed decision of heterologous transfusion
    Delayed order for supplemental blood products
    Delayed addition of venous routes
    Shortage of rapid transfusion apparatus 
    Air embolism 
Manpower
    Delayed call for help 
    Shortage of anesthesiologists
    Shortage of nurses and clinical engineers
Anesthetic management
    Anesthetic drug-induced hypotension
    Hypothermia
    Hyperkalemia
    Anesthesia-induced hemorrhage
12.4
7.4
9.0
5.3
7.6
0.3
6.0
10.0
3.7
1.9
2.9
1.2
1.6154 www.ekja.org
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coagulopathy by inhibiting activation of coagulation factors 
as well as by inhibiting platelet aggregation. Although rapid 
infusion/transfusion apparatus is effective in massive/rapid 
transfusion, incorrect handling of the apparatus can cause 
massive air embolism. Air embolism by this mechanism was 
reported in 0.3% of patients with massive hemorrhage.
Emergency or massive transfusion practices: present 
status
    We investigated the outcome of massive hemorrhage both 
in elective and in emergency patients, as well as the amount of 
blood stored in hospitals with more than 500 beds [11]. Fig. 2 
shows that mortality rate increases with increasing blood loss 
and with decreasing minimum intraoperative hemoglobin 
level [11]. It should be mentioned that some patients whose 
minimum intraoperative hemoglobin level was maintained 
above 5-7 g/dl died following massive hemorrhage. The 
permissive limit of anemia has been reported to be 6 g/dl in 
a young healthy patient [12,13]. Some authors suggested that 
healthy patients were able to withstand a hemoglobin level 
of 5 g/dl in acute isovolemic hemodilution [14]. However, our 
investigation showed that maintaining hemoglobin level above 
permissive limits of anemia did not guarantee a good outcome. 
Possible explanations for this are as follows: (i) our study 
population might have had a low cardiopulmonary reserve 
or high oxygen consumption, and (ii) intravascular volume 
was coincidentally low due to rapid or massive hemorrhage. 
Complete examination of cardiopulmonary reserve is 
sometimes difficult, especially in an emergency setting. The 
rate of blood loss is unpredictable, and it is sometimes more 
rapid than RBC transfusion, resulting in deficits in intravascular 
volume and oxygen delivery. When solutions or blood products 
other than RBCs are rapidly infused or transfused to counter 
rapid blood loss, dilutional anemia develops. Therefore, a 
margin of safety in hemoglobin level should be considered 
in massive hemorrhage. In the British guidelines on massive 
hemorrhage, maintaining hemoglobin levels of more than 8 g/
dl is recommended, while it is stated that the general indication 
of RBC transfusion is hemoglobin levels of less than 6 g/dl 
[13]. We should also be aware that hemoglobin level is a poor 
indicator of blood loss in acute situations [13].
    In the 1,257 patients whose intraoperative blood loss 
exceeded 5,000 ml, median, 75th percentile, and 90th percentile 
of amount of RBC transfusion were 20, 30, and 50 units (one 
unit corresponds to 200 ml of whole blood in Japan), respec-
tively [11]. Meanwhile, the mean stored amount of RBCs was 
as follows: O-type, 11 units; A-type, 12 units; B-type, 8 units; 
and AB-type, 6 units [11]. The ratio of population of O-, A-, B-, 
and AB-type in Japan is 4 : 3 : 2 : 1. Therefore, when blood loss 
exceeds 5,000 ml, the stored amount of ABO-identical RBCs 
does not meet the requirements in many hospitals, even those 
with more than 500 beds, indicating that emergency delivery 
of ABO-identical RBCs from blood banks and/or transfusion 
of ABO-compatible, non-identical RBCs are required. We 
investigated 2,597 patients between 2006 and 2008, whose 
blood loss exceeded 5,000 ml and blood type was other than 
O-type. The overall mortality was 19%, while uncross-matched 
ABO-identical and ABO-compatible, non-identical RBCs were 
transfused in only 9% and 1.7% of patients, respectively. In 407 
patients whose minimum intraoperative hemoglobin level was 
less than 5 g/dl, mortality was 37%, while uncross-matched 
ABO-identical and ABO-compatible, non-identical RBCs were 
transfused in only 20% and 5.4% of patients, respectively. In 164 
patients who required cardiac massage in the operating room, 
mortality was 73%, while uncross-matched ABO-identical and 
Fig. 2. Outcome of 1,257 patients whose intraoperative blood loss exceeded 5,000 ml in terms of the function of blood loss (A) and the minimum 
intraoperative hemoglobin level (B). 155 www.ekja.org
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ABO-compatible, non-identical RBCs were transfused in only 
20% and 7.9% of patients, respectively. 
Hemolytic reactions due to emergency transfusion 
practices
    What disturbed emergency blood transfusion practices 
in the operating room or in blood transfusion services? The 
background is that the Ministry of Health, Labor, and Welfare 
has strongly recommended ABO-identical blood transfusion 
in order to prevent incompatible blood transfusion. The 4th 
edition of the guidelines for practice of transfusion established 
in 2009 by the Ministry of Health, Labor, and Welfare states that, 
in an emergency, “ABO-compatible, non-identical RBCs are 
permitted to be transfused in exceptional circumstances” . In 
these public guidelines, the fundamental concept that saving 
the patient’s life is the priority in blood transfusion for critical 
hemorrhage is lacking. As a consequence, medical practitioners 
have not been educated about emergency transfusion practices. 
Indeed, 40% of hospitals with more than 500 beds reported that 
there were some impediments that disturbed ABO-compatible, 
non-identical RBC transfusion [12]. The major impediment 
was insufficient consensus among medical staff, followed by 
safety issues and hesitation among medical staff including 
anesthesiologists.
    What is the level of safety of uncross-matched ABO-identical 
or ABO-compatible, non-identical RBC transfusion? If the 
antibody screen is negative, type-specific uncross-matched 
blood will result in a hemolytic reaction in less than 1/50,000 
units, which is lower than the reported incidence of delayed 
hemolytic reactions in the ordinary setting [5]. In Japanese 
patients who are not registered in computer cross-matching, 
the incidence of delayed hemolytic reaction is estimated to 
be about 1%, because the possibility of RhD negativity is 0.5% 
and the possibility of carrying irregular antibodies that may 
cause hemolytic reactions including anti-RhE, anti-Fy
a&b, and 
anti-Jk
a&b antibodies is 0.5% in Japan. Indeed, FDA reported 25 
fatal hemolytic reactions probably due to irregular antibodies 
between 2005 and 2008, although whether uncross-matching 
was responsible was not mentioned [15].
    It has been reported that 100,419 units of emergency O-type 
RBC transfusion during the Vietnam War did not cause lethal 
complications, while 24 patients who were transfused with 
cross-matched blood or type-specific blood exhibited lethal 
hemolytic reactions during the same period owing clerical error 
[9]. Dutton et al. [16] have summarized 4 reports and their own 
results concerning the safety of uncross-matched O-type RBCs 
in civilian trauma patients. They analyzed 790 patients or 2,041 
units of RBCs and did not find severe or lethal complications, 
although at least 13 patients had transient alloimmunization. 
These low rates of complications might be partly explained 
by immunosuppression that is associated with massive 
hemorrhage or hemorrhagic shock. The other explanation is 
that transfused RBCs are lost from the circulation so rapidly that 
they cannot induce immune reactions.
    The incidence of acute hemolytic reactions mainly due to 
major mismatch has been reported to be 1/25,000-50,000 
units [5]. The Japanese Society of Transfusion Medicine and 
Cell Therapy reported that the incidence of major mismatch is 
1/200,000 bags, of which about one-third of cases were related 
to RBC transfusion.
    Therefore, we can speculate that the incidence of lethal 
hemolytic reactions associated with uncross-matched O-type 
RBCs is very low, and the incidence of delayed hemolytic 
reactions in patients whose irregular antibody is not examined 
is about 1%. On the other hand, the mortality rate is 19% when 
blood loss exceeds 5,000 ml. If hemorrhage is associated with 
severe anemia, critical events such as severe hypotension, or 
cardiac arrest, the mortality rate increases stepwise.
    Risk-benefit analysis clearly shows that there is no rationale to 
abandon emergency transfusion practices to avoid associated 
complications.
Crisis Management
Declaration of emergency
    Crisis management in critical bleeding resembles that in 
disaster medicine [17]. In order to save as many victims’ lives as 
possible in major incident medical management, organization 
of many related staff is mandatory. The principal components 
of disaster medicine are summarized as CSCATTT: C for 
command, S for safety, C for communication, A for assessment, 
T for triage, T for treatment, and T for transport. If we replace S 
for safety of a bleeding patient in the operating room and T for 
transport of blood products from a blood bank to a hospital, we 
can adapt CSCATTT to actions against massive hemorrhage. 
The major problems underlying major incident medical manage-
ment at the scene of an accident are reported to be a failure in 
communication as well as hesitation to declare an emergency.
    To rapidly deal with critical bleeding in the operating room, 
effective communication among responsible staff is mandatory, 
especially between anesthesiologists and surgeons, between 
operating rooms and blood transfusion services, and between 
blood transfusion services and a blood bank. When critical 
bleeding occurs, a commander, a person in charge, is appointed. 
Senior physicians of the anesthesiology department or of the 
department in charge are candidates for commander. The first 
task for a commander is to carry out a medical assessment of 
the hemodynamic status of a patient and the most likely course 156 www.ekja.org
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of ongoing bleeding, and then to declare an emergency.
    Guidelines for the management of critical bleeding in 
obstetrics published in 2010 by 5 related scientific societies 
including JSA proposed the urgency code of hemorrhage 
as shown in Fig. 3. This code was introduced to facilitate 
communication between the operating room and blood 
transfusion services. The idea is the same as a triage tag in 
disaster medicine, and staff other than doctors can easily 
understand the order of urgency. The urgency code clarifies 
what each medical staff should do according to bleeding and 
a patient’s status. For example, when code I or code red is 
declared by a commander in the operating room, staff in blood 
transfusion services have to try their best to supply blood 
products including ABO-compatible, non-identical RBCs to 
the operating room as promptly and at as sufficient levels as 
possible. The process is dynamic, and coding is usually altered 
by further bleeding or after treatment. Because this urgency 
code should also be applied to facilitate communication 
between hospitals and blood banks in the near future, it is 
important to standardize the urgency code soon.
    Declaration of code I, an emergency, by a commander is 
also essential for calling out as many supportive medical staff 
including anesthesiologists, physicians of the department 
in charge, operating room nurses, and clinical engineers 
as possible and for correcting plans of surgical procedures 
and anesthetic management as well as infusion/transfusion 
practices. Keeping pre-operative plans of patient management 
will often provide catastrophic events. As mentioned in 
disaster medicine, the initial step of crisis management will 
be frustrated by reluctance to declare an emergency, failure 
in communication among medical staff including medical 
engineers in blood transfusion services, and a shortage of 
manpower. Professional pride, fear of criticism of calling 
many staff unnecessarily, or escape from the difficult situation 
can cause indecision of declaring code I. None of these is 
acceptable. Survival of the patient has to be prioritized in taking 
action against critical bleeding.
    A commander comprehensively assesses hemodynamics, test 
data, the hemostatic condition, and blood product supply system, 
and then consults the surgeon regarding the continuation of 
planned surgery or change of surgical procedure. A commander 
has to keep in mind the following points: prompt decision-
making, concrete as well as concise instructions, following 
the algorithm, watching for violations by medical staff, and 
confirmation of exact time recording. The other important task 
of a commander is to cancel an emergency, and to offer an 
opportunity to evaluate the validity of the responses later.
Blood Transfusion
Red blood cells
    When the blood type is unclear, but time is short, O-type RBCs 
are used (Table 2). However, transfusion of ABO-compatible, 
non-identical RBCs and/or infusion of artificial colloid solution 
affect blood-type examination and cross-matching test, 
making it difficult to switch promptly to ABO-identical RBC 
transfusion. Therefore, before the start of ABO-compatible, 
non-identical RBC transfusion and/or artificial colloid solution, 
blood samples for blood-type examination and cross-matching 
should be taken, especially in an emergency outpatient.
    When the blood type is clear, but time is short, the cross-
matching test is omitted, and the same ABO-type blood is used. 
When ABO-identical RBCs are not available, ABO-compatible, 
non-identical RBCs are transfused. When the patient’s blood 
Fig. 3. Urgency code for emergency 
blood transfusion. RBCs to be permitted 
differ among hospitals according to 
the amount of stock, manpower of the 
blood supply center especially during 
nights/weekends, and the time required 
for emergency blood supply from blood 
banks. Code color for I, II, III is red, 
yellow, green as in the case of a triage tag. 
*RBC: red blood cell.
Table 2. Priority of ABO-type Blood Products in an Emergency
Patient
Blood products
RBC FFP/PC
A
B
AB
O
Unknown
A > O
B > O
AB > A = B > O
O
O
A > AB > B
B > AB > A
AB > A = B
O > AB > A = B
AB > A = B
RBC: red blood cell, FFP: fresh frozen plasma, PC: platelet con-
centrate.157 www.ekja.org
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type is AB, A- or B-type RBCs should be considered prior to 
O-type RBC transfusion (Table 2). For RhD-negative patients, 
the same ABO-type RhD-positive RBCs can be used on 
condition that anti-RhD antibody is absent. Even when a patient 
has an irregular antibody, ABO-compatibility is prioritized 
without performing a cross-matching test.
    When a blood transfusion service supplies uncross-matched 
RBCs, its staff will start a cross-matching test thereafter. If the 
test reveals incompatibility, blood transfusion service staff 
should immediately report the result to operating room staff 
before the corresponding RBCs are transfused. In order to 
switch to the same ABO-type blood transfusion, the cross-
matching test with newly collected fresh blood from the patient 
is performed by the saline method, and then ABO-identical 
RBCs are used.
    Delayed hemolysis may occur several hours to 3 weeks after 
the completion of transfusion of irregular antibodies and anti-
RhD antibody. Symptoms are severer the earlier reactions 
occur. When hemolysis develops, a febrile reaction and 
hemoglobinuria develop. Laboratory examination shows a 
decrease in hemoglobin level by more than 2 g/dl, an increase 
in LDH, an increase in indirect bilirubin level, positive direct 
globulin test, and positive cross-matching [5]. When hemolysis 
is confirmed, forced diuresis is induced by diuretics and 
infusion. Administration of anti-RhD immunoglobulin is 
considered when RhD-positive RBCs are transfused to an RhD-
negative patient.
RBC salvage
    When a large-volume RBC transfusion is necessary owing to 
massive hemorrhage, transfusion of autologous blood recovered 
from the surgical field is useful. When the blood loss is greater 
than 3 L, blood is aspirated, washed, and returned. The recovery 
rate of RBCs is about 40%. RBC salvage can minimize allogeneic 
RBC transfusion, including ABO-compatible, non-identical 
RBC transfusion.
    In general, RBC salvage is thought to be contraindicated in 
patients undergoing resection of malignant tumors. Although 
infusion of malignant cells may cause their dissemination, 
salvaging RBCs is recommended to avoid hemorrhagic death, 
whether salvaged RBCs are transfused or not. RBC salvage 
is also thought to be contraindicated in patients undergoing 
Cesarean section because of the presence of fetal RBCs, fetal 
skin surface cells, and amniotic fluid. Taking into consideration 
the fact that hemorrhage is the leading cause of maternal 
death, RBC salvage should be considered after the delivery of 
fetus and placenta. Indeed, ASA recommended RBC salvage 
in an emergency even in Cesarean section [18]. An absolute 
contraindication of blood salvage is wound contamination.
Irradiation
    Post-transfusion graft-versus-host disease is lethal. Even 
though RBCs and platelet concentrate (PC) are depleted of 
leukocytes, irradiation is mandatory. Therefore, irradiated blood 
products should be ordered when hospitals order supplemental 
blood products to a blood bank. It is also advisable that blood 
transfusion service start irradiation before the operating room 
orders supplemental blood products.
Massive and rapid transfusion
    Multiple large-bore venous access is mandatory to treat 
critical hemorrhage. Central venous catheterization should 
be considered when required, even though central venous 
catheterization itself has some risks. Rapid infusion of cold 
blood products or rapid infusion of calcium through a central 
venous line should be avoided.
    Rapid transfusion devices are useful to treat critical 
hemorrhage, although several precautions are required: (i) the 
indication has to be strictly complied with, (ii) only devices that 
are periodically and routinely maintained and inspected should 
be used, (iii) a person fully familiar with a device’s operation 
must always be present and must take responsibility for using 
the device, (iv) air-detection and occlusion alarm has to be 
set at “ON” throughout use, and (v) particular attention must 
be paid to extravascular deviation of intravenous catheters. 
Warming blood products with the exception of PC is mandatory 
when the transfusion speed exceeds 50 ml/kg/hr.
    Complications due to massive and rapid transfusion include 
metabolic changes (citrate intoxication, hyperkalemia, and 
hypothermia), dilution coagulopathy, and circulatory or iron 
overload. 
Fresh frozen plasma
    Massive hemorrhage is often associated with coagulopathy. 
Hemorrhage induces loss and consumption of coagulation 
factors. Infusion and transfusion of only RBCs cause dilution 
of coagulation factors [19]. Acidosis, hypothermia, as well 
as artificial colloid infusion inhibit coagulation even if levels 
of coagulation factors are adequate [3,20]. Recent evidence 
suggests that acute endogenous coagulopathy develops before 
coagulation factor depletion in injured victims [21]. Early 
traumatic coagulopathy develops in the presence of tissue 
hypoperfusion. In this context, the situation is quite different in 
elective surgery [20]. In elective surgery, trauma is controlled, 
normovolemia is maintained, and blood loss is replaced in a 
timely fashion.
    Once coagulopathy develops, it increases blood loss. 158 www.ekja.org
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Because coagulopathy and blood loss make a vicious circle, 
prevention of coagulopathy is important. A general indication 
to transfuse fresh frozen plasma (FFP) is blood loss of more 
than one circulating blood volume or PT-INR greater than 
2.0 [11]. However, in massive hemorrhage, British guidelines 
recommend that a therapeutic target of PT-INR should be 
less than 1.5, and that FFP should be given without PT-INR 
examination when blood loss is anticipated to exceed one 
circulating blood volume [13]. In such an emergency, we should 
also consider that thawing fresh frozen plasma will take about 
30 min. Deficiency of fibrinogen develops earlier than that 
of any other coagulation factors: 100 mg/dl after loss of 120-
170% of blood volume [3,5,22]. Since 5 units of FFP (400 ml) is 
equivalent to 1 g of fibrinogen, it increases the concentration by 
about 30 mg/dl in a person weighing 60 kg (circulating plasma 
volume: 3 L). Fibrinogen concentrate or cryoprecipitate is 
preferable when urgent treatment of coagulopathy is required, 
but volume loading is not desirable. Because PT-INR is not a 
sensitive parameter of fibrinogen deficiency, we have to directly 
measure fibrinogen levels. Another pitfall concerning PT-INR 
is that hypercoagulation develops in injured patients instead 
of the increase in PT-INR, which might cause pulmonary 
thromboembolism [23]. Thromboelastogrphy has been shown 
to be more sensitive to detect a hypercoagulable state [5,23].
    Although off-label use of recombinant factor VIIa is reported 
to be effective in the treatment of massive hemorrhage in some 
settings, its efficacy and safety remain to be investigated [24]. 
It should be used after the completion of replacement of both 
platelets and coagulation factors, and when co-administration 
of tranexamic acid is contraindicated. Otherwise, use of 
recombinant factor VIIa may cause thrombotic complications 
such as myocardial infarction, stroke, and pulmonary embolism. 
Platelet concentrate
    Transfusion of platelets is ineffective until bleeding becomes 
surgically controllable. Platelets are transfused when the platelet 
count decreases below 50,000/mm
3 or blood loss is exceeds 
×1.5 blood volume. British guidelines recommend that platelet 
counts should be targeted to be above 75,000/mm
3 to maintain 
them above 50,000/mm
3 [13]. In a person weighing 60 kg, 10 
units of platelets (containing 2 × 10
11 platelets) are expected to 
increase the count by about 25,000/mm
3.
Proactive administration of plasma and platelets
    Massive transfusion practices in military trauma and 
then in civilian trauma have suggested that a 1 : 1 : 1 ratio 
of RBC : FFP : PC improves survival rate when a transfusion 
of more than 20 units (corresponding to 4,000 ml of blood) 
of RBCs is required within 24 h [25]. The idea is that the early 
identification and management of coagulopathy may help 
to better control traumatic hemorrhage and may reduce 
hemorrhagic mortality [21]. Whether the same concept can be 
applied to the elective surgical setting has yet to be elucidated. 
Because obstetric massive hemorrhage is usually associated 
with consumption coagulopathy, early management of 
coagulopathy is also required. It has been reported that the 
decrease in fibrinogen level is an early predictor of the severity 
of postpartum hemorrhage [26].
    AB-type FFP/PC can be safely transfused irrespective of 
patients’ ABO-blood type and of volume transfused. However, 
A-type and B-type FFP/PC can also be safely transfused 
irrespective of a patient’s ABO-type (Table 2), unless trans-
fusion volume does not exceed 2,000 ml. Transfusion of 
compatible, non-identical FFP and PC makes early treatment of 
coagulopathy possible. 
Surgical procedures
    A commander and a surgeon should discuss and decide 
surgical procedures: accomplishment of scheduled procedures, 
change to the minimum procedures, bimanual compression of 
the bleeding point, temporary packing [27], clamps of the artery 
or the aorta, or damage control surgery [28]. Hypothermia, 
acidosis, persistent hypotension, and shortage of blood products 
are the absolute indications for damage control surgery. After 
temporary wound closure with packing, improvement of the 
circulatory dynamics, coagulation system, oxygen transport 
ability, hypothermia, and acid-base equilibrium should be 
attempted in the ICU. Hemostasis by interventional radiology 
is also considered. In obstetric patients, prophylactic arterial 
embolization and catheterization have been reported [29].
Establishment of hospital actions
    To rapidly deal with critical bleeding, not only cooperation 
between anesthesiologists and surgeons but also the linkage of 
operating rooms with blood transfusion services (transfusion 
division, laboratory test room, and others) and a blood bank 
are important. Related staff should have a thorough knowledge 
of the blood supply system of the hospital (blood transport 
and stock systems as well as time required for the procedures 
in blood transfusion services), the supply system of blood 
transfusion services, and the blood storage system in the 
operating room. It is desirable that the hospital transfusion 
committee prepares hospital regulations on ‘actions to be taken 
against critical bleeding’ , and practices them in simulation. 
Once an emergency has been declared, the validity of surgical 
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should be discussed in a morbidity and mortality conference, 
and re-evaluation of hospital actions should be carried out. It is 
also important to notify the actions as well as their background 
to all concerned staff.
    The process by which the hospital transfusion committee 
prepares hospital regulations itself helps hospital staff to agree 
on emergency blood transfusion practices. Hospital actions 
should include the following: (i) agreement about assigning a 
commander and declaring an emergency, (ii) urgency code, 
(iii) emergency blood transfusion practices according to each 
urgency code (may differ depending on hospital size, stocks of 
blood products, activities of blood transfusion services during 
nights or weekends, time required for emergency supply 
of blood products from a blood bank), (iv) actions of blood 
transfusion services after supplying uncross-matched RBCs, (v) 
patient management after emergency blood transfusion, (vi) 
identification of patient and blood products (some computer-
assisted collation systems released by manufacturers do not 
work in the case of emergency blood transfusion practices, 
and how to deal with multiple patients in the emergency room 
should be stated), (vii) irradiation, (viii) labeling the blood 
products to inform all related staff that emergency blood 
transfusion is going on, (ix) blood salvage, (x) off-label use of 
coagulation factor products, (xi) damage control surgery and 
intervention radiology, and (xii) informed consent.
    A commander is requested to have sufficient clinical 
experience as well as the ability to make decisions appropriately 
and immediately, implying that he or she might experience 
strong mental stress. Hospital actions can minimize the 
deviation of aptitude as well as ability of a commander, and 
his or her mental stress. Hospital actions can also minimize 
hesitation of staff of blood transfusion services to deliver ABO-
compatible, non-identical RBCs during nights or weekends. 
Hospital actions are meant to be followed as an organization, 
not as individuals, indicating that a person disobeying hospital 
actions is responsible for the resultant bad outcome of a patient. 
Therefore, hospital actions can eliminate antagonism between 
departments and with regard to seniority, which might delay 
or disturb emergency blood transfusion practices. Hospital 
actions also clarify the points and rules to be confirmed. By 
obeying hospital actions, misunderstandings and lapses can 
be eliminated, and everybody concerned can point out a 
commander’s error. Establishing hospital actions enables a 
structured response against critical hemorrhage.
Centralization
    In critical hemorrhage, a patient’s life mainly depends on 
manpower and the availability of blood products. In terms of 
manpower, the quantity as well as the quality is important. 
Anesthesiologists, surgeons, radiologists, nurses, and clinical 
engineers in the operating room and staff of blood transfusion 
services are all essential to save a patient’s life [10,11]. The 
survival rate after massive or critical hemorrhage might be 
lower in a hospital where surgeons can perform damage control 
surgery and radiologists can perform interventional radiology 
[27-29]. Even in JSA-certified training hospitals with more than 
500 beds, there are insufficient ABO-identical RBCs to deal with 
blood loss exceeding 5,000 ml [11]. This implies that hospitals 
that perform risky procedures should be centralized. Table 3 
shows the results of a JSA survey, which investigated 2,257 
patients (1,281 elective and 633 emergency patients) with blood 
loss exceeding 5,000 ml. The results indicate that aortic surgery 
and liver transplantation should be centralized because of their 
high frequency among patients with massive hemorrhage, high 
incidence of massive hemorrhage, and high mortality rate. It 
seems that we should also pay attention to hepatic resection: 
the incidence of massive hemorrhage is low, but mortality after 
hemorrhage is higher than that of liver transplantation. The 
idea of centralization might be supported by the relationship 
between surgical volume and mortality [30,31]. To reduce 
hemorrhagic death, centralization of aortic and hepatic surgery 
should be prioritized. 
    In summary, many human factors are involved in the 
development of hemorrhage into critical events. Hemorrhagic 
mortality and morbidity in the operating room can be reduced 
by a systemic, not an individual, approach. Establishment of 
hospital actions to be taken to deal with critical hemorrhage 
Table 3. Proportion, Incidence, and Mortality of Patients whose Blood Loss Exceeded 5,000 ml (from the Standpoint of Surgical Procedures)
Proportion (%) Incidence of hemorrhage (%) Mortality after hemorrhage (%)
Thoracic aortic replacement
Abdominal aortic replacement
Heart surgery
Liver transplantation
Hepatic resection
Intrapelvic region
17.7
12.0
7.1
6.5
10.4
16.5
6.5
3.5
0.5
28.9
1.7
0.3
22.1
25.6
22.4
4.8
18.3
4.0
Intraoperative Blood Loss Exceeded 5,000 ml in 2,257 Patients Among 324,335 Anesthetic Procedures in 2007 and 2008.  This JSA Survey was 
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depends on the overall capability of risk and crisis management 
of a hospital.
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